VT News

James Bouknight

Ask VT AI
View News Summary
  • AbbVie inks $1.9B deal with IGI for myeloma drug ISB 2001, a promising trispecific antibody with potential to deliver deeper, more durable responses in immuno-oncology.
  • UK economy contracts again amid tariffs and taxes, raising concerns about the economic outlook.
  • US government bars undocumented immigrants from accessing federal benefits, including Head Start, in a move to prioritize resources for US citizens.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • AbbVie inks $1.9B deal with IGI for myeloma drug ISB 2001, a promising trispecific antibody with potential to deliver deeper, more durable responses in immuno-oncology.
  • UK economy contracts again amid tariffs and taxes, raising concerns about the economic outlook.
  • US government bars undocumented immigrants from accessing federal benefits, including Head Start, in a move to prioritize resources for US citizens.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from James Bouknight

Top Topics

Trending in U.S.

World

Sport